Activist 13D/13G Filings - Flagship VentureLabs IV LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-02-14
1:00 pm
Purchase		13GRUBIUS THERAPEUTICS INC
RUBY		Flagship VentureLabs IV LLC38,606,526
42.7%		38,606,526increase
(New Position)		View
2022-10-17
4:32 pm
Purchase		13DAXCELLA HEALTH INC
AXLA		Flagship VentureLabs IV LLC29,251,545
39.8%		10,383,760increase
(+55.03%)		View
2022-09-23
4:31 pm
Unchanged		13DAXCELLA HEALTH INC
AXLA		Flagship VentureLabs IV LLC18,867,785
35.8%		0
(Unchanged)		View
2022-07-07
5:00 pm
Purchase		13DSERES THERAPEUTICS INC
MCRB		Flagship VentureLabs IV LLC23,493,063
18.9%		8,443,072increase
(+56.10%)		View
2022-03-18
08:30 am
Purchase		13DAXCELLA HEALTH INC
AXLA		Flagship VentureLabs IV LLC18,867,785
36.4%		6,319,371increase
(+50.36%)		View
2020-11-25
4:30 pm
Sale		13DSERES THERAPEUTICS INC
MCRB		Flagship VentureLabs IV LLC15,049,991
16.5%		-6,596,914decrease
(-30.48%)		View
2020-05-20
5:00 pm
Purchase		13DAXCELLA HEALTH INC
AXLA		Flagship VentureLabs IV LLC12,548,414
35%		3,800,000increase
(+43.44%)		View
2019-06-28
4:30 pm
Purchase		13DSERES THERAPEUTICS INC
MCRB		Flagship VentureLabs IV LLC21,646,905
30.96%		21,646,905increase
(New Position)		View
2019-05-23
4:16 pm
Purchase		13DAXCELLA HEALTH INC
AXLA		Flagship VentureLabs IV LLC8,748,414
38.1%		8,748,414increase
(New Position)		View